Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads by Date Must reads for theWeek ending April 26, 2020 ACEI/ARBs linked with survival in hypertensive, Chinese COVID-19 patients, Exposure to air pollution tied to risk of developing schizophrenia, Paliperidone palmitate long-acting injectable may improve negative symptoms, Sarcosine may improve clinical symptoms in schizophrenia, Cigarette smoking a risk factor for schizophrenia, More must reads Must reads for theWeek ending April 19, 2020 N.Y. universal testing: Many COVID-19+ pregnant women are asymptomatic, Most e-consults not followed by specialist visit, Klotho allele lowers APOE4-associated risk of Alzheimer’s, Female patients with MDD show more dysfunctional attitudes than male patients, Physical frailty is a predictor of incident MDD, More must readsMust reads for theWeek ending April 12, 2020 Treatment for RA, SpA may not affect COVID-19 severity, More must readsMust reads for theWeek ending April 5, 2020 Vortioxetine offers potential benefit as adjunctive to antipsychotics in chronic schizophrenia, Long-acting aripiprazole injectable may be effective during first episode schizophrenia, Schizophrenia: Niacin skin flush response linked to plasma triglyceride levels, Serum epidermal growth factor not predictive of treatment response in schizophrenia, PCOS tied to increased risk of schizophrenia, More must readsMust reads for theWeek ending March 29, 2020 Reports suggest possible in utero transmission of novel coronavirus 2019, Hormone therapy boosts body image in transgender youth, Targeting gut bacteria may improve levodopa uptake, Schizophrenia risk higher among relatives of affected individuals , Schizophrenia: Plasma kynurenic acid levels may serve as biomarker for cognitive impairment, More must readsPages« first 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 last »
